CPIX - Cumberland Pharmaceuticals GAAP EPS of -$0.17 revenue of $9.12M March, 07 2023 04:25 PM Cumberland Pharmaceuticals Inc. 2023-03-07 16:25:41 ET Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): FY GAAP EPS of -$0.17. Revenue of $9.12M (+9.9% Y/Y). For further details see: Cumberland Pharmaceuticals GAAP EPS of -$0.17, revenue of $9.12M